UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000020929
Receipt number R000024148
Scientific Title Effect of the anti-obesity mixture in metabolic-syndrome : a randomized controlled trial
Date of disclosure of the study information 2016/02/08
Last modified on 2016/02/08 12:56:53

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effect of the anti-obesity mixture in metabolic-syndrome : a randomized controlled trial

Acronym

Effect of the anti-obesity mixture in metabolic-syndrome :

Scientific Title

Effect of the anti-obesity mixture in metabolic-syndrome : a randomized controlled trial

Scientific Title:Acronym

Effect of the anti-obesity mixture in metabolic-syndrome :

Region

Japan


Condition

Condition

Metabolic-syndrome

Classification by specialty

Medicine in general

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To assume the effect of the anti-obesity mixture in metabolic-syndrome :

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

SF8
Body fat
Fasting blood sugar level
Triglyceride, T-Cho,LDL-Cho,HDL-Cho,TG

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Food

Interventions/Control_1

Test food

Interventions/Control_2

Control food

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

70 years-old >

Gender

Male and Female

Key inclusion criteria

20<=age<70
Male and female
Out patients
25<=BMI<=30
Healthy adults
Nonsmoker
Those who are able to obtained consent document

Key exclusion criteria

Patient with severe disease
Those who cannot avoid drinking the day before study.
Those who were participating in other clinical trials within one month
Those who may suffer the risk.
Those who may not provide enough data.

Target sample size

20


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Megumi Hayakawa

Organization

GMC Ltd.

Division name

CEO

Zip code


Address

108-3 Higashi-matsumoto Gosho-City Nara, Japan

TEL

0744-47-4395

Email

info@gmc-earth.com


Public contact

Name of contact person

1st name
Middle name
Last name Megumi Hayakawa

Organization

GMC Ltd.

Division name

CEO

Zip code


Address

108-3 Higashi-matsumoto Gosho-City Nara, Japan

TEL

0744-47-4395

Homepage URL


Email

info@gmc-earth.com


Sponsor or person

Institute

GMC Ltd.

Institute

Department

Personal name



Funding Source

Organization

GMC Ltd.

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2016 Year 02 Month 08 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2015 Year 12 Month 13 Day

Date of IRB


Anticipated trial start date

2016 Year 01 Month 22 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2016 Year 02 Month 08 Day

Last modified on

2016 Year 02 Month 08 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000024148


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name